Single Cell Multiomics Market: Current Analysis and Forecast (2021-2027)
Emphasis on Product Type (Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics, Single Cell Metabolomics); Application (Oncology, Cell Biology, Neurology, Immunology, Others); and Region & Country.
Single Cell Multiomics Market is expected to exceed the market valuation of more than US$ XX billion in 2027 and is expected to grow at a significant CAGR of 19% during the forecast period (2021-2027). Single-cell isolation and barcoding technologies are advancing at an unprecedented pace, this is opening numerous opportunities in profiling DNA, mRNA, and proteins at a single-cell resolution. Bulk multiomics analysis are efficient in obtaining a comprehensive understanding of cellular events. Bulk Multiomcs can be multidimensional genomic or proteogenomic analyses. The cell type-specific gene regulation has enabled the development of single-cell multiomics analysis. The cardinal features of the single cell multiomics analysis include integrative analysis of molecules to characterize cells and their functions in pathophysiological processes using molecular signatures and single cell isolation technologies, barcoding and sequencing to measure multiple types of molecules from individual cells. With the help of high throughput sequencing greater than 70 proteins can be investigated in parallel, by incorporating unique sequences with every PEA antibody pair.
Key factors for the single cell multiomics market growth include rising rate of chronic and infectious diseases caused by viruses. According to the World Health Organization (WHO), timely and effective treatment of infectious diseases can help raise national productivity levels by as much as 20%. This technology will help increase our understanding of the biological cellular heterogeneity. Furthermore, the growth of biotechnology and pharmaceutical sectors is also increasing the demand for non-invasive instruments.
Various Mutations and Their Global Frequency, 2021
10x Genomics, Inc., 1CellBio, MissionBio, NanoString Technologies, Inc., Fluidigm Corporation, Fluxion Biosciences, Bio-Rad Laboratories, Inc., Celsee, Inc., BGI Genomics Co. Ltd., GE LifeSciences are some of the prominent players operating in the Single Cell Multiomics Market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.
Insights Presented in the Report
“Amongst Product Type, Single Cell Transcriptomics segment holds the major share”
Based on product type, the single cell multiomics market is segmented into Single Cell Genomics, Single Cell Proteomics, Single Cell Transcriptomics and Single Cell Metabolomics. Amongst product type, the single cell transcriptomics segment of the XX market was valued at US$ XX billion in 2020 and is likely to reach US$ XX billion by 2027 growing at a CAGR of XX% from 2021-2027. Transcriptome is the collection of all transcription products in a cell including messenger RNA, ribosomal RNA, transport RNA, and non-coding RNA and narrowly refers to the collection of all mRNAs present under a particular physiological condition.
“Amongst Application, Oncology Research segment holds the major share”
Based on application, the single cell multiomics market is segmented into Oncology, Cell Biology, Neurology, Immunology, and Others. Amongst application, oncology accounted for a market valuation of US$ XX billion in 2020 and is expected to reach US$ XX billion by the year 2027, at a CAGR of XX% over the analyzed period. In the tumor cells environment, there are large number of specific mutations present as surface markers. The treatment plan can be affected by the extensive heterogeneity of cells in the body, the dynamic process of changes and the timelines of expression related factors. All these factors have fueled the demand for multiomics in oncology.
“North America represents one of the largest markets of Single Cell Multiomics market”
For a better understanding of the market dynamics of the Single Cell Multiomics market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Italy, United Kingdom, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC) and Rest of the World. North America dominated the market and grabbed around XX% market share owing to increasing R&D in biotechnology companies and its wide application.
Reasons to buy this report:
- The study includes market sizing and forecasting analysis validated by authenticated key industry experts
- The report presents a quick review of overall industry performance at one glance
- The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
- Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
- The study comprehensively covers the market across different segments
- Deep dive regional level analysis of the industry
Customization Options:
Single Cell Multiomics market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
Table of Contents
Analyzing the historical market, estimation of the current market, and forecasting the future market of the Single Cell Multiomics market were the three major steps undertaken to create and analyze the adoption of Single Cell Multiomics in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the Single Cell Multiomics market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below:
Analysis of Historical Market Size
Step 1: In-Depth Study of Secondary Sources:
Detail secondary study was conducted to obtain the historical market size of the Single Cell Multiomics through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.
Step 2: Market Segmentation:
After obtaining the historical market size of the Single Cell Multiomics market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments included in the report as Product Type and Application. Further country-level analyses were conducted to evaluate the overall adoption of Single Cell Multiomics in that region.
Step 3: Factor Analysis:
After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of Single Cell Multiomics. Further, we conducted factor analysis using dependent and independent variables such as increasing number of genomics studies and increasing adoption of personalized medicine for genetic disorders. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, merger and acquisition, business expansion, and product launches in the Single Cell Multiomics sector across the globe.
Current Market Size Estimate & Forecast
Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the Single Cell Multiomics market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.
Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., top-down/bottom-up approach was applied to arrive at the market forecast about 2027 for different segments and subsegments across the major markets globally. The research methodology adopted to estimate the market size encompasses:
- The industry’s market size, in terms of value (US$) and the adoption rate of Single Cell Multiomics across the major markets domestically
- All percentage shares, splits, and breakdowns of market segments and sub-segments
- Key players in the Single Cell Multiomics market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market
Market Size and Share Validation
Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.
Split of Primary Participants in Different Regions
Market Engineering
Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the Single Cell Multiomics market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of type and their type of the Single Cell Multiomics market.
The main objective of the Single Cell Multiomics Market Study
The current & future market trends of Single Cell Multiomics were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends were determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:
- Analyze the current and forecast market size of Single Cell Multiomics in terms of value (US$). Also, analyze the current and forecast market size of different segments and sub-segments
- Segments in the study include areas of type and their subtypes
- Define and analysis of the regulatory framework for the Single Cell Multiomics industry
- Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
- Analyze the current and forecast market size of the Single Cell Multiomics market for the major region
- Major regions studied in the report include North America (the U.S, Canada, and Rest of North America), Europe (Germany, United Kingdom, France, Spain, Italy, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Others), and the Rest of the World
- Company profiles of the Single Cell Multiomics market and the growth strategies adopted by the market players to sustain in the fast-growing market
Deep dive regional level analysis of the industry
Related Reports
Customers who bought this item also bought
Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)
Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country
October 8, 2024
